[Treatment of conjunctival epithelial tumors: brachytherapy with ruthenium-106].
BACKGROUND
Treatment of conjunctival epithelial tumors is not standardized because it is difficult to compare large series in this rare disease. Surgical excision is usual, but the recurrence rate has led several authors to propose alternative therapies.


METHODS
During the past 20 years, brachytherapy using ophthalmic applicators has been developed and the results of different studies have confirmed the usefulness of this therapy. We report a retrospective study of 13 patients presenting with a conjunctival epithelial tumor treated with ruthenium106 applicators and followed up in our department since 1987.


CONCLUSIONS
There was no recurrence during a mean follow-up of 48 months. Complications depended on the size of the area treated and the dose of radiation.
Buc
D
D
Service d'Ophtalmologie, Hôpital G. Montpied, CHU de Clermont-Ferrand.
Pilon
F
F
Donnarieix
D
D
Kemeny
J-L
JL
Bacin
F
F
Rigal
D
D
D000328:Adult; D017677:Age Distribution; D000368:Aged; D000369:Aged, 80 and over; D001706:Biopsy; D001918:Brachytherapy / Q000009:adverse effects / Q000295:instrumentation / Q000379:methods*; D003230:Conjunctival Neoplasms / Q000175:diagnosis / Q000453:epidemiology / Q000532:radiotherapy* / Q000601:surgery; D005260:Female; D005602:France / Q000453:epidemiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D009367:Neoplasm Staging; D009375:Neoplasms, Glandular and Epithelial / Q000175:diagnosis / Q000453:epidemiology / Q000532:radiotherapy* / Q000601:surgery; D011182:Postoperative Care; D011879:Radiotherapy Dosage; D018714:Radiotherapy, Adjuvant; D012189:Retrospective Studies; D012429:Ruthenium Radioisotopes / Q000009:adverse effects / Q000627:therapeutic use*; D017678:Sex Distribution; D013326:Strontium Radioisotopes / Q000627:therapeutic use; D016896:Treatment Outcome
D012429:Ruthenium Radioisotopes; D013326:Strontium Radioisotopes